Word count: 5,152; Tables:2; Figures: 3; References: 111
Funding: This publication was supported by the EAACI Task Force “Diagnosis and Management of Allergic Bronchopulmonary Aspergillosis”
Acknowledgments: EAACI Working Group Infection; EAACI Working Group Aerobiology and Pollution
Conflicts of interest: JV reports speaker and consultancy fees in the past 5 years from Meda Pharma (Mylan), Novartis, Sanofi, Thermo Fisher Scientific, outside the submitted work. The other authors declare no competing interests in relation to this study.